Search

Search Results

Found 64 items.

Effects of the availability of new oral anticoagulants in patients with non-valvular atrial fibrillation in the real world: the NAIF study

Francesco Ventrella, Franco Mastroianni, Sergio Cappello, Luigi Iamele, Samantha Errico, Massimo Errico

176-183

06-07-2016

1417

PDF: 900

HTML: 341
Assessment and predictors of inappropriate dose of direct oral anticoagulants

Mosaad O. Almegren

09-01-2024

719

pdf: 347

HTML: 112
Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation

Tommaso Sacquegna, Anna Zaniboni, Andrea Rubboli, Gaetano Procaccianti, Michela Crisci, Fabiola Maioli, Giorgia Arnone, Giuseppe Di Pasquale

314-322

15-12-2015

1914

PDF: 881

HTML: 1227
Sex-gender and atrial fibrillation treatment in the AntiThrombotic Agents in Atrial Fibrillation (ATA-AF) study

Cecilia Politi, Tiziana Ciarambino, Letizia Riva, Stefania Frasson, Donata Lucci, Gualberto Gussoni, Lucio Gonzini, Mauro Campanini, Michele Gulizia, Giuseppe Di Pasquale, Giovanni Mathieu, on behalf of ATA-AF Steering Committee and Investigators

207-212

16-02-2016

1631

PDF: 1429

Appendix: 654

HTML: 544
The practical management of bleedings during treatment with direct oral anticoagulants: the emergency reversal therapy

Luca Masotti, Giancarlo Landini, Grazia Panigada

48-58

24-12-2013

1322

PDF: 900
Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics

Luca Masotti, Mauro Campanini

1-7

24-12-2013

9488

PDF: 2672
Emergency management of patients being treated with oral anticoagulants

Franco Manzato, Massimo Franchini

234-241

17-12-2013

1039

PDF: 819

HTML: 302
The treatment of venous thromboembolism with new oral anticoagulants

Davide Imberti

29-35

24-12-2013

1033

PDF: 811
Direct oral anticoagulants in real practice: which doses for which patients. Limitations and bleeding risk compared to vitamin K antagonists

Giancarlo Landini, Luca Masotti

41-47

24-12-2013

881

PDF: 773
Stroke prevention in atrial fibrillation: findings from Tuscan FADOI Stroke Registry

Luca Masotti, Rinaldo Innocenti, Stefano Spolveri, Irene Chiti, Grazia Panigada, Cristiana Seravalle, Giancarlo Landini, Alberto Fortini, Rino Migliacci, Raffaele Laureano, for Tuscan FADOI Stroke Registry Investigators

134-140

12-06-2014

1517

PDF: 1187

Appendix: 563

HTML: 622
Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation

Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Cecilia Becattini, Maurizio Paciaroni, Daniel Augustin Godoy, Roberto Cappelli, Giancarlo Landini, Grazia Panigada, Ido Iori, Domenico Prisco, Giancarlo Agnelli

8-21

24-12-2013

1271

PDF: 835
A review on management of antiphospholipid syndrome in clinical practice

Carmine Siniscalchi, Pietro Rossetti, Gaetano Carolla, Pierpaolo Di Micco, Adriano Stella, Michele Riva

13-09-2023

2147

PDF: 899

HTML: 53
Monitoring strategies for patients treated with the new oral anticoagulants and the need for laboratory evaluation of hemostasis

Andrea Fontanella, Pierpaolo Di Micco

59-64

24-12-2013

903

PDF: 881
New oral anticoagulants: key messages for clinicians

Matteo Giorgi-Pierfranceschi, Chiara Cattabiani, Francesco Dentali

74-84

24-12-2013

1236

PDF: 844
Pregnancy and heart disease: what Internists should know

Riccardo Gerloni, Domenico Panuccio

288-304

11-09-2017

1264

PDF: 638

HTML: 263
Cryptogenic stroke

Michele Stornello, Roberto Cappellani, Giuseppe Micieli, Simona Sacco, Stefano Spolveri, Roberto Sterzi, Danilo Toni, Antonio Carolei

185-194

30-09-2016

1830

PDF: 1070

HTML: 581
Characteristics and clinical management of acute pulmonary embolism in real world: findings from TUSCAN-PE study

Luca Masotti, Filippo Pieralli, Grazia Panigada, Francesco Corradi, Rino Migliacci, Salvatore Lenti, Alessandro Tafi, Carlo Nozzoli, Giancarlo Landini, for TUSCAN-PE Investigators

125-133

03-06-2014

2055

PDF: 1248

Appendix: 1081

HTML: 747
Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows

Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Daniel Godoy, Grazia Panigada, NiccolÃ² Napoli, Giancarlo Landini, Roberto Cappelli, Ido Iori, Domenico Prisco, Giancarlo Agnelli

153-169

23-10-2012

1625

PDF: 1924
Clinical characteristics of very old patients hospitalized in internal medicine wards for heart failure: a sub-analysis of the FADOI-CONFINE Study Group

Paolo Biagi, Roberto Nardi, Concetta Isabella Baldo, Giovanni Scanelli, Domenico Panuccio, Andrea Bonanome, Fabio Miserocchi, Luigi Lusiani, Erminio Bonizzoni, Mauro Campanini, Carlo Nozzoli, Giorgio Vescovo, on behalf of the FADOI-CONFINE Study Group

19-28

17-03-2014

1833

PDF: 1068

HTML: 657
Apixaban

Gianluca Airoldi, Mauro Campanini

128-134

07-03-2013

1104

PDF: 1760
Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes

Andrea Rubboli

22-28

24-12-2013

952

PDF: 714
Point-of-care ultrasonography role in detecting inferior vena cava thrombosis in a patient with low back pain: a case report

Daniele Castellucci, Miguel Angel Casado Suela, Mercedes Duffort Falco, Juan Salillas Hernando, Pilar Medrano Izquierdo, Alessandra Dimino, Antonio Carroccio, Juan Torres Macho

09-04-2024

260

PDF: 292

HTML: 69
Patent foramen ovale and ischemic stroke: more shadows than lights? What the internist should know

Andrea Donti

175-184

30-09-2016

1549

PDF: 876

HTML: 923
Prognostic factors for SARS-CoV-2 nasopharyngeal swab negativity: a multicentric study

Ombretta Para, Lorenzo Caruso, Caterina Pestelli, Giulia Pestelli, Giacomo Fedi, Stefano Guidi, Alessia Abenante, Carlo Nozzoli

31-12-2022

950

PDF: 170

HTML: 11
How to manage new oral anticoagulants in case of surgery

Davide Imberti

36-40

24-12-2013

876

PDF: 798
Antithrombotic drugs with adjuvant action against COVID-19

Pierpaolo Di Micco, Gianluca Di Micco, Vincenzo Russo, Andrea Fontanella

241-244

22-12-2020

897

PDF: 459

HTML: 12
Fondaparinux

G. Airoldi, M. Campanini

44-52

03-05-2013

1014

PDF: 4597
Thrombophilias: therapeutic employment of direct oral anticoagulants in venous hypercoagulable states

Federico Cacciapuoti

136-142

17-09-2020

723

PDF: 477

HTML: 293
A dangerous adverse event in the use of dabigatran

Manuel Monti, Giovanni Maria Vincentelli, Francesco Borgognoni, Giuseppe Murdolo, Feliciano Menghini

250-251

09-11-2015

1556

PDF: 862

HTML: 253
The heart failure in Internal Medicine in Tuscany: the SMIT Study

Valerio Verdiani, Grazia Panigada, Alberto Fortini, Luca Masotti, Simone Meini, Paolo Biagi, for the SMIT Study Group

349-355

15-12-2015

1546

PDF: 818

Appendix: 992

HTML: 748
Management of major bleeding in patients treated with direct oral anticoagulants: from experience to standardized protocols

Sara Mascia, Anna Maria Ferrari, Nicola Macarone Palmieri, Elisa Romagnoli, Chiara Catena, Serena Scarabottini, Francesca Mori, Lucio Brugioni

43-48

17-06-2020

872

PDF: 584

HTML: 142
Embolic stroke of undetermined source: a retrospective analysis from an Italian Stroke Unit

Marco Masina, Annalena Cicognani, Carla Lofiego, Simona Malservisi, Riccardo Parlangeli, Alessandro Lombardi

202-206

30-09-2016

1557

PDF: 802

HTML: 803
Vorapaxar

Gianluca Airoldi, Mauro Campanini

88-95

24-04-2013

1124

PDF: 619

HTML: 219
Anticoagulation in the early phase of non-valvular atrial fibrillation-related acute ischemic stroke: where do we stand?

Luca Masotti, Elisa Grifoni, Alessandro Dei, Vieri Vannucchi, Federico Moroni, Grazia Panigada, Stefano Spolveri, Giancarlo Landini

24-31

03-01-2019

1325

PDF: 732

HTML: 70
Results of prospective multicenter study on heart failure on Campania Internal Medicine wards: the FASHION study

Fernando Gallucci, Ilaria Ronga, Andrea Fontanella, Generoso Uomo, and the FASHION Study Group

184-190

14-06-2017

1283

PDF: 710

HTML: 450
Optimal duration of anticoagulant therapy in patients with venous thromboembolism

Gualtiero Palareti

235-244

14-09-2018

1429

PDF: 1731

HTML: 257
Differences in in-hospital clinical course, management and outcome between stroke with and without atrial fibrillation. A retrospective analysis from the SETI (Studio Epidemiologico Toscano Ictus) study

P. Biagi, S. Bocchini, R. Laureano, G. Panigada, G. Vescovo

14-22

03-05-2013

958

PDF: 741
Posterior circulation lesions are more frequently associated with early seizures after a stroke

Argjend Shala, Afrim Blyta, Nexhmedin Shala, Dren Boshnjaku, Pranvera Ibrahimi, Fisnik Jashari

16-01-2024

875

PDF: 274

HTML: 146
Clinical management of spontaneous intracranial haemorrhage associated with oral anticoagulants: a case series

Luca Masotti, Alessandro Pampana, Paolo Pennati, Giancarlo Landini

34-44

07-03-2013

723

PDF: 983
Treatment and secondary prophylaxis of venous thromboembolism with direct oral anticoagulants in patients with severe hereditary thrombophilia

Pasquale Madonna, Anna Guida, Maria Gabriella Coppola, Paolo Tirelli, Ernesto Grasso

18-03-2021

1017

PDF: 499

HTML: 51
Dabigatran etexilate: a direct thrombin inhibitor

M. Dugnani

56-62

03-05-2013

868

PDF: 1429
Mean platelet volume as diagnostic and therapeutic marker of risk and prognosis of heart disease

Henshaw Uchechi Okoroiwu, Christopher Ogar Ogar

10-14

11-01-2018

1606

PDF: 715

HTML: 639
The diagnostic pathway embolism: from the Emergency Department to the Internal Medicine Unit

Attilia Maria Pizzini, Daniela Galimberti, Stefano De Pietri, Mauro Silingardi, Maria Cristina Leone, Annamaria Ferrari, Ido Iori

4-9

22-03-2016

1533

PDF: 1093

HTML: 531
An unusual cause of massive hemoptysis

Silvia Maestroni, Martino Cellerini, Antonio Brucato

71-74

01-07-2016

1282

PDF: 820

HTML: 378
How artificial intelligence during the pandemic modified the role of a biomarker as d-dimer

Pierpaolo Di Micco, Francesca Futura Bernardi, Giovanni Maria Fusco, Alessandro Perrella

20-11-2023

809

PDF: 252

HTML: 27
Thrombocytopenia induced by a taurine-containing energy drink: an adverse reaction to herbal medicine

Federico Pasin, Emanuela Porro, Francesco Frattini, Pierpaolo Vescovi, Massimo Franchini, Paolo Sansoni

259-261

27-02-2014

1920

PDF: 962

HTML: 1211
A rare case of multiple myeloma with several atypical manifestations

Clelia Nasti, Raffaele Natale, Annadora Morena, Roberta Della Pepa, Fabrizio Pasanisi, Lidia Santarpia

04-07-2024

1939

PDF: 450

HTML: 133
The FADOI (Federation of Associations of Hospital Doctors on Internal Medicine) position paper on cardiovascular prevention in the higher risk complex patients

Mauro Campanini, Giuliano Pinna, Roberto Nardi, on behalf of the FADOI Cardiovascular Prevention Position Statements Group

387-404

15-12-2015

1967

PDF: 847

Appendix: 454

HTML: 1459
Gender medicine: an up-date

Cecilia Politi, Tiziana Ciarambino, Flavia Franconi, Lucrezia De Feudis, Maria Carolina Mayer, Alessandra Martignoni, Ilaria Giovi, Michela Tonani, Salvatore La Carrubba, Anna Maria Moretti, Carmen Martino, Giovanni Scanelli

96-106

24-04-2013

2015

PDF: 865

HTML: 468
Long-term impact of COVID-19 requiring elevated oxygen support and safety of prolonged positive pressure ventilation

Francesca Salvotti, Riccardo Pellegrinelli, Veronica Geroldi, Francesca Leidi, Vittorio Scipione, Gigliola Flamminio, Antonella Pastori, Claudia Agabiti-Rosei, Carolina De Ciuceis, Damiano Rizzoni, Gianluca Edoardo Mario Boari

18-10-2023

619

PDF: 348

HTML: 77

1 - 50 of 64 items 1 2 > >>

© PAGEPress 2008-2024 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy